LMAT vs OGN · P/E 35, rev $136.9M vs P/E 3.4, rev $3.02B
LeMaitre Vascular Inc (LMAT) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
LeMaitre Vascular Inc (LMAT) is a medical instruments & supplies company listed on US.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported LMAT revenue for 2026-06-30 was $136.9M. Net income was $32.7M. LMAT currently screens at market cap $2.16B and trailing P/E 34.8.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
LMAT currently screens at market cap $2.16B and trailing P/E 34.8. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the LMAT and OGN stock pages for the full models.
Not investment advice.